Genomic Diversity of Streptomyces clavuligerus: Implications for Clavulanic Acid Biosynthesis and Industrial Hyperproduction
Open Access
- 12 October 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (20) , 10992
Abstract
Streptomyces clavuligerus is a species used worldwide to industrially produce clavulanic acid (CA), a molecule that enhances antibiotic effectiveness against β-lactamase-producing bacterial strains. Despite its low inherent CA production, hyper-producing strains have been developed. However, genomic analyses specific to S. clavuligerus and CA biosynthesis are limited. Genomic variations that may influence CA yield were explored using S. clavuligerus strain genomes from diverse sources. Despite the slight differences obtained by similarity index calculation, pan-genome estimation revealed that only half of the genes identified were present in all strains. As expected, core genes were associated with primary metabolism, while the remaining genes were linked to secondary metabolism. Differences at the sequence level were more likely to be found in regions close to the tips of the linear chromosome. Wild-type strains preserved larger chromosomal and plasmid regions compared to industrial and/or hyper-producing strains; such a grouping pattern was also found through refined phylogenetic analyses. These results provide essential insights for the development of hyper-producing S. clavuligerus strains, attending to the critical demand for this antibiotic enhancer and contributing to future strategies for CA production optimization.Keywords
Funding Information
- Ministerio de Ciencia Tecnología e Innovación (Minciencias), Colombia (933–2023)
This publication has 57 references indexed in Scilit:
- Streptomyces behavior and competition in the natural environmentCurrent Opinion in Microbiology, 2022
- An integrative-omics analysis of an industrial clavulanic acid-overproducing Streptomyces clavuligerusApplied Microbiology and Biotechnology, 2022
- Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usageClinical Microbiology and Infection, 2020
- Improved production of clavulanic acid by reverse engineering and overexpression of the regulatory genes in an industrial Streptomyces clavuligerus strainJournal of Industrial Microbiology and Biotechnology, 2019
- CRISPR/dCas9‐Mediated Multiplex Gene Repression in StreptomycesBiotechnology Journal, 2018
- Streptomyces clavuligerus shows a strong association between TCA cycle intermediate accumulation and clavulanic acid biosynthesisApplied Microbiology and Biotechnology, 2018
- Proteomics analysis of global regulatory cascades involved in clavulanic acid production and morphological development inStreptomyces clavuligerusJournal of Industrial Microbiology and Biotechnology, 2016
- BlastKOALA and GhostKOALA: KEGG Tools for Functional Characterization of Genome and Metagenome SequencesJournal of Molecular Biology, 2016
- Improvement of clavulanic acid production by Streptomyces clavuligerus with peanut derivativesAnnals of Microbiology, 2011
- Improvement of clavulanic acid production in Streptomyces clavuligerus by genetic manipulation of structural biosynthesis genesBiotechnology Letters, 2011